Neuland Laboratories Limited - Transformation towards niche APIs?

[VALUE2017]

From the Neuland Reading Room: Peptide Trends in 2024

JUDGEMENT DAY FOR NEULAND ON 26.09.2024 as FDA may approve block buster drug KARXT.

Schizophrenia Space Anticipates First-in-Class FDA Approval for BMS’ KarXT